Fexofenadine 30mg Tablet Franchise in Ahmedabad

Antihistamine Tablet Supplier in Bangalore

Fexofenadine Tablet Distributor in Hyderabad

Allergy Relief Tablet Franchise Opportunity in Jaipur

Seasonal Allergy Tablet Stockist in Mumbai
Fexofenadine Tablet Export & Manufacturing in Chandigarh

Home/Products /fexofenadine-30mg-tablet

Fexoform 30 Tablet

Composition : Fexofenadine (30mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Fexoform 30 Tablet contains Fexofenadine 30mg, a clinically proven second-generation antihistamine that provides fast and effective relief from allergy symptoms, including sneezing, runny nose, itchy eyes, and hives. Its non-drowsy formulation allows patients to remain alert while managing symptoms.

Fexofenadine works by selectively blocking peripheral H1 receptors, preventing histamine-mediated allergic reactions. Its once-daily dosage ensures convenient administration and consistent symptom control for adults and children above approved age limits.

For hospitals, clinics, and distributors, Fexoform 30 Tablet is a high-demand allergy-care product, widely prescribed by general physicians, ENT specialists, and dermatologists. Seasonal allergies and chronic allergic conditions maintain steady demand throughout the year.

Adding Fexoform 30 Tablet to your product portfolio strengthens your allergy and ENT segment, offering opportunities in hospital supply, pharmacy distribution, institutional procurement, export markets, and third-party manufacturing. Its high prescription rate and non-drowsy efficacy make it a profitable and strategically valuable product for pharmaceutical distributors.

Read More

About the Product

Fexoform 30 Tablet contains Fexofenadine 30mg, a clinically proven second-generation antihistamine that provides fast and effective relief from allergy symptoms, including sneezing, runny nose, itchy eyes, and hives. Its non-drowsy formulation allows patients to remain alert while managing symptoms.

Fexofenadine works by selectively blocking peripheral H1 receptors, preventing histamine-mediated allergic reactions. Its once-daily dosage ensures convenient administration and consistent symptom control for adults and children above approved age limits.

For hospitals, clinics, and distributors, Fexoform 30 Tablet is a high-demand allergy-care product, widely prescribed by general physicians, ENT specialists, and dermatologists. Seasonal allergies and chronic allergic conditions maintain steady demand throughout the year.

Adding Fexoform 30 Tablet to your product portfolio strengthens your allergy and ENT segment, offering opportunities in hospital supply, pharmacy distribution, institutional procurement, export markets, and third-party manufacturing. Its high prescription rate and non-drowsy efficacy make it a profitable and strategically valuable product for pharmaceutical distributors.

Common side effects include headache, dizziness, nausea, and dry mouth.

Fexoform 120 Tablet is indicated for the relief of symptoms associated with seasonal allergic rhinitis and chronic idiopathic urticaria.

Consult a healthcare provider before use if you are pregnant, nursing, or taking other medications. By incorporating Fexoform 120 Tablet into your allergy management plan, you can enhance your quality of life and minimize the disruptive impact of allergies on your daily activities. Always follow the recommended dosage guidelines and ensure proper storage to maintain the effectiveness of the medication.

Store in a cool, dry place away from direct sunlight and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation